Browse the evidence

Elevated plasma free fatty acids (FFAs) induce endothelial dysfunction primarily by downregulating the AMPK/PI3K/Akt/eNOS signaling pathway, thereby reducing nitric oxide (NO) production and causing vasoconstriction.

If you have metabolic issues like obesity or type 2 diabetes, your body may have high levels of free fatty acids in your blood. This specifically damages the lining of your blood vessels by blocking the production of nitric oxide, which keeps arteries flexible. Managing metabolic health through diet and exercise can lower these fatty acids and protect your vascular function.

Elevated free fatty acids promote endothelial dysfunction by activating inflammatory pathways (NF-κB) and oxidative stress (NADPH oxidase), leading to reduced nitric oxide availability and increased vasoconstrictors like endothelin-1.

High levels of fatty acids in the blood trigger inflammation and oxidative stress in blood vessel walls. This damage reduces the body's ability to produce nitric oxide (a vessel relaxer) and increases substances that tighten vessels. Reducing metabolic stress helps lower this inflammatory burden.

Integration of food and nutrition into healthcare systems requires sustainable funding, clinician education, and rigorous research to be effective and scalable.

Advocate for your healthcare system to integrate food interventions. This means pushing for sustainable funding, better clinician nutrition education, and rigorous research to ensure these programs are effective and accessible.

Obstructive sleep apnea syndrome (OSAS) causes intermittent hypoxia (IH) and hypercapnia, which trigger gut microbiota dysbiosis, intestinal barrier impairment, and altered metabolites, leading to systemic oxidative stress, inflammation, and sympathetic activation.

If you have OSAS, treating the airway collapse is essential to stop the cycle of intermittent hypoxia that damages your gut and increases systemic inflammation. This goes beyond just feeling rested; it prevents long-term metabolic and cardiovascular harm.

Nocturnal rostral fluid shift, where fluid accumulated in the legs during the day redistributes to the neck upon lying down, increases tissue pressure and upper airway collapsibility, predisposing individuals to OSAS.

If you have leg swelling, try elevating your legs during the day or wearing compression stockings. This can reduce the amount of fluid that shifts to your neck at night, potentially easing airway collapse.

Mitochondrial dysfunction, driven by the accumulation of somatic mtDNA mutations and altered dynamics (fission/fusion imbalance), is a primary hallmark and causal driver of aging and age-related pathologies, rather than merely a consequence.

Focus on interventions that stimulate mitochondrial biogenesis and quality control, such as exercise (which induces mitohormesis) and metabolic stressors. The goal is to maintain the balance between creating new mitochondria (biogenesis) and removing damaged ones (mitophagy) to prevent the accumulation of dysfunction that drives aging.

Reactive Oxygen Species (ROS) are not the primary cause of aging; instead, they are a consequence of mitochondrial dysfunction, and moderate ROS increases can extend lifespan via mitohormesis.

Avoid excessive antioxidant supplementation that might blunt the adaptive benefits of exercise. Embrace moderate metabolic stress (like exercise) which generates ROS as a signal to improve mitochondrial efficiency and longevity.

In patients with nonalcoholic steatohepatitis (NASH), circulating bile acid profiles are significantly altered, characterized by increased primary bile acids (specifically conjugated cholate and taurocholate) and decreased secondary bile acids, which correlates with increased severity of hepatic steatosis, inflammation, and fibrosis.

This research highlights that NASH involves specific disruptions in bile acid metabolism, particularly an increase in primary bile acids like cholate and a decrease in secondary ones. While this paper does not prescribe a specific diet, it suggests that the composition of bile acids is a key driver of liver damage. Future interventions may focus on modulating bile acid profiles (e.g., via FXR agonists or dietary fiber to influence microbiome-derived secondary bile acids) to reduce inflammation and fibrosis risk.

PPARgamma activation in immune cells (macrophages, dendritic cells, T cells) suppresses pro-inflammatory signaling pathways (NF-kB, AP-1) via transrepression, reducing the production of inflammatory cytokines like TNF-alpha, IL-1beta, and IL-6.

Chronic inflammation is linked to metabolic disease. PPARgamma activation (naturally or via drugs) helps calm this inflammation by blocking key inflammatory signals in immune cells.

Obesity is associated with elevated circulating succinate levels, which are determined by a specific gut microbiota signature characterized by a higher ratio of succinate-producing bacteria (Prevotellaceae, Veillonellaceae) to succinate-consuming bacteria (Odoribacteraceae, Clostridaceae).

High circulating succinate, linked to obesity and cardiovascular risk, is driven by an imbalance in gut bacteria (too many producers, too few consumers). Weight loss interventions, particularly those involving a Mediterranean diet, can restore this balance by reducing succinate-producing bacteria and increasing succinate-consuming ones, thereby lowering circulating succinate levels.

Acarbose treatment improves metabolic parameters (BMI, insulin resistance, lipid profile) in type 2 diabetes patients by altering gut microbiota to increase the ratio of primary to secondary bile acids, but this benefit is contingent on the patient's baseline microbiota composition.

If you are starting treatment for Type 2 Diabetes, ask your doctor about the potential role of your gut health. This research suggests that a specific type of diabetes medication (Acarbose) works better for people who have a certain gut bacteria profile (high Bacteroides). It alters bile acids to improve metabolism, not just blood sugar. This is not a general recommendation for all patients, but a stratification strategy.

Hypertrophic white adipocytes in obesity secrete pro-inflammatory cytokines (TNFα, IL-6, IL-1β) and adipokines (leptin, resistin) that induce local and systemic insulin resistance and chronic inflammation, leading to metabolic disorders like type 2 diabetes and cardiovascular disease.

If you are obese, your fat tissue is actively sending signals that promote inflammation and insulin resistance, which worsens your metabolic health. This is not just 'extra weight'; it is a biologically active state. Addressing obesity through sustainable lifestyle changes can reduce the secretion of these harmful adipokines and improve metabolic markers.

Untreated obstructive sleep apnea (OSA) imposes a massive global economic burden, with undiagnosed cases in the US alone costing an estimated $149.6 billion annually due to lost productivity, comorbidities, and accidents.

If you suspect you have sleep apnea (snoring, daytime sleepiness), seek diagnosis. The economic and health costs of leaving it untreated are substantial, including increased risk of accidents and chronic diseases. Treatment, particularly CPAP, is often cost-effective and can save money in the long run by preventing comorbidities.

Increasing long-chain omega-3 fatty acid intake (via supplements or dietary replacement) does not significantly reduce all-cause mortality, cardiovascular mortality, or major cardiovascular events in primary or secondary prevention populations.

If you are trying to prevent heart disease or reduce your risk of dying from cardiovascular causes, simply taking omega-3 supplements or eating more fatty fish is unlikely to make a significant difference based on current high-quality evidence. Focus on proven lifestyle factors like blood pressure management, smoking cessation, and overall diet quality rather than relying on omega-3 supplementation for prevention.

Gut microbiota dysbiosis is associated with the development and severity of specific diabetic complications, including nephropathy, retinopathy, neuropathy, and cardiovascular disease.

Your gut health is linked to your diabetes complications. While high blood sugar is a major factor, your gut bacteria also play a role in inflammation and disease progression. This doesn't mean you are to blame, but it does mean that supporting your gut health (through diet and potentially probiotics) might be part of a comprehensive strategy to protect your kidneys, eyes, and heart.

Daily oral taurine supplementation (1000 mg/kg body weight) in middle-aged mice extends median life span by 10-12% and increases life expectancy at 28 months by 18-25% while improving health span across multiple organ systems.

For middle-aged individuals, maintaining adequate taurine levels may support healthy aging. While this study used high doses in mice, human observational data links lower taurine levels to adverse health outcomes. Consult a healthcare provider before starting supplementation, especially if you have existing health conditions.

Taurine supplementation improves health span metrics in middle-aged mice, including reduced body weight gain, improved bone mass and strength, enhanced muscle endurance and strength, reduced anxiety, improved memory, better glucose homeostasis, and ameliorated immune cell prominence.

Taurine supplementation in middle age may support overall health, including bone, muscle, and metabolic function. While human trials are needed, these findings suggest potential benefits for healthy aging.

Traditional probiotics and prebiotics do not show significant impact on the amelioration of chronic inflammation-related diseases in general, necessitating the development of next-generation, disease-targeted strains.

Do not rely on over-the-counter, generic probiotics to treat chronic conditions like obesity, diabetes, or IBD. Current evidence shows they generally lack significant impact. Instead, consult healthcare providers for emerging, strain-specific therapies or next-generation probiotics designed for your specific condition.

Equol is produced by only 25-50% of humans via gut bacteria, and this 'equol producer' status determines whether dietary soy provides significant health benefits.

Only about half of people produce 'equol' from soy. If you don't, eating soy might not give you the hormonal benefits others get. You can test your status or take equol supplements directly.

Testosterone replacement therapy (TRT) is contraindicated in men with untreated prostate or breast cancer, and is not recommended for improving cognitive function, depressive symptoms, or exercise capacity in hypogonadal men.

Do not take testosterone to fix your memory, mood, or physical frailty. It is not effective for these issues. Also, do not take it if you have untreated prostate or breast cancer.

There is no universal 'magic number' for ideal sleep duration; optimal sleep is individualized based on genetic, environmental, and performance factors rather than a single population-wide recommendation.

Stop obsessing over hitting a specific number like 8 hours. Instead, use your own body as the metric: if you wake up feeling rested and function well during the day, your sleep duration is likely appropriate for you. If you struggle, look at quality and timing, not just quantity.

Low dietary fiber intake increases the abundance of the gut bacterium Collinsella, which is positively correlated with circulating insulin levels in overweight and obese pregnant women.

If you are overweight or obese and pregnant, ensuring adequate dietary fiber intake (aiming for >28g/day as recommended) may help maintain a healthier gut microbiota balance by keeping Collinsella levels low. This is associated with lower circulating insulin levels, which may support better metabolic health during pregnancy. Focus on increasing fiber from whole food sources rather than supplements.

A mortality risk score based on DNA methylation levels of ten specific CpG sites in peripheral blood strongly predicts all-cause mortality, independent of chronological age and the 'epigenetic clock'.

This research identifies a blood test that can predict your risk of dying from any cause more accurately than your age alone. The test looks at the methylation status of 10 specific genes. A higher score indicates higher risk. While this doesn't tell you how to change your health, it highlights the importance of managing risk factors like smoking, blood pressure, and diabetes, as these are linked to the methylation patterns found. Prevention of smoking-related DNAm changes may improve longevity.

Gut microbiota composition influences energy homeostasis and obesity development through mechanisms involving short-chain fatty acids (SCFAs), bile acid metabolism, and systemic inflammation.

If you are considering probiotics for weight management, look for specific strains like Lactobacillus casei Shirota, L. gasseri, L. rhamnosus, or L. plantarum, as well as Bifidobacterium infantis, longum, and breve. However, do not expect all probiotics to work, as some strains have shown no effect or even increased weight gain in studies.